Study on the Effectiveness of dTap Vaccine in Boosting Immunity Against Diphtheria, Tetanus, and Whooping Cough in Healthcare Workers

3 1 1 1

What is this study about?

This clinical trial is focused on studying the immune response to a booster vaccination in healthcare workers. The diseases being studied are diphtheria, tetanus, and pertussis (commonly known as whooping cough). The treatment used in this study is a vaccine called dTap, which is designed to boost immunity against these diseases. The vaccine contains several components, including diphtheria toxoid, tetanus toxoid, and various parts of the pertussis bacteria that help the body recognize and fight the infection.

The purpose of the study is to understand how the immune system of healthcare workers responds to the dTap booster vaccine. Participants will receive the vaccine and their immune response will be measured before and after vaccination. The study will involve two visits where participants will complete questionnaires and provide blood samples. These samples will help researchers measure the levels of specific antibodies, which are proteins made by the immune system to fight infections, and other immune responses.

The study will track changes in the immune system over a period of four weeks after the booster vaccination. This includes measuring the levels of antibodies specific to pertussis, as well as the immune response to diphtheria and tetanus. The results will help determine how well the vaccine works in boosting immunity among healthcare workers who are regularly in contact with infants, a group particularly vulnerable to these diseases.

1 initial visit

Upon joining the study, you will attend an initial visit. During this visit, you will complete a questionnaire about your health and work environment.

A blood sample will be taken to measure your current immunity levels against diphtheria, tetanus, and pertussis (whooping cough).

2 vaccination

You will receive a booster vaccination with the dTap vaccine. This vaccine is administered as an intramuscular injection, which means it is given with a needle into a muscle.

The vaccine contains components to boost your immunity against diphtheria, tetanus, and pertussis.

3 post-vaccination period

After receiving the vaccine, you will have a period of 28 days before the next visit. During this time, your body will develop an immune response to the vaccine.

4 follow-up visit

You will return for a follow-up visit 28 days after the vaccination. During this visit, another blood sample will be taken to assess the immune response generated by the vaccine.

Additional tests may be conducted to measure specific immune responses, such as antibody levels and other immune cell activities.

Who Can Join the Study?

  • Must be a healthcare worker who regularly works with infants under 12 months old and needs a dTap booster vaccination every 5 years. The dTap vaccine protects against diphtheria, tetanus, and pertussis (whooping cough).
  • It has been more than 4 years since the last dTap vaccination.
  • Willing to follow the study procedures, which include attending 2 visits, completing questionnaires, providing blood and MLF samples, and planning to receive the dTap vaccine.
  • Both male and female participants are eligible.

Who Cannot Join the Study?

  • Participants must not have any known allergies to the components of the dTap vaccine. The dTap vaccine is a booster shot for diphtheria, tetanus, and pertussis (whooping cough).
  • Participants should not have received any other vaccines within 4 weeks before the study starts.
  • Participants must not have any serious chronic illnesses. A chronic illness is a long-lasting health condition that requires ongoing medical attention.
  • Participants should not be pregnant or planning to become pregnant during the study period.
  • Participants must not have any immune system disorders. The immune system is the body’s defense against infections and illnesses.
  • Participants should not be taking medications that affect the immune system, such as steroids. Steroids are drugs that reduce inflammation and affect the immune system.
  • Participants must not have had a previous severe reaction to any vaccine.
  • Participants should not be participating in another clinical trial at the same time.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name City Country Status
Vmixayukomyxsmik herihyxndzhmpgd Turku Finland

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
Finland Finland
Not recruiting
01.03.2024

Trial locations

Investigated drugs:

dTap vaccine is a combination vaccine that helps protect against three serious diseases: diphtheria, tetanus, and pertussis (whooping cough). This vaccine is given as a booster to help strengthen the body’s defense system, or immunity, against these diseases. In this clinical trial, health care workers receive the dTap vaccine to see how their immune systems respond to it, both before and four weeks after getting the booster shot. The goal is to understand how well the vaccine works in boosting immunity against these diseases in people who work in health care settings.

Diphtheria – Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae. It primarily affects the mucous membranes of the throat and nose. The disease begins with a sore throat, fever, and chills. As it progresses, a thick, gray membrane forms in the throat, which can lead to difficulty breathing and swallowing. The bacteria produce a toxin that can spread through the bloodstream, potentially affecting the heart and nerves. Without intervention, the infection can cause severe complications.

Tetanus – Tetanus is a serious bacterial infection caused by Clostridium tetani. The bacteria produce a toxin that affects the nervous system, leading to muscle stiffness and spasms. The disease often starts with muscle stiffness in the jaw, commonly known as lockjaw. As it progresses, the stiffness spreads to other muscles, causing severe muscle spasms and difficulty swallowing. The spasms can be strong enough to cause bone fractures. The bacteria typically enter the body through wounds or cuts.

Pertussis (Whooping Cough) – Pertussis, also known as whooping cough, is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It starts with symptoms similar to a common cold, such as a runny nose, mild cough, and fever. As the disease progresses, severe coughing fits develop, which can be followed by a high-pitched “whoop” sound when breathing in. The coughing fits can lead to vomiting and exhaustion. The disease is particularly dangerous for infants and can lead to complications such as pneumonia. The bacteria spread through respiratory droplets from coughing or sneezing.

Trial ID:
2024-511478-56-00
Trial Phase:
Therapeutic confirmatory (Phase III)

Other Trials to Consider

  • Study of Long-term Pertussis Immunity in Children at Age 4 Years Following Maternal Vaccination During Pregnancy

    Not recruiting

    3 1 1 1
    Finland